Literature DB >> 27652671

Variation of Burkholderia cenocepacia virulence potential during cystic fibrosis chronic lung infection.

Ana S Moreira1, Dalila Mil-Homens1, Sílvia A Sousa1, Carla P Coutinho1, Ana Pinto-de-Oliveira1, Christian G Ramos1, Sandra C Dos Santos1, Arsénio M Fialho1, Jorge H Leitão1, Isabel Sá-Correia1.   

Abstract

During long-term lung infection in cystic fibrosis (CF) patients, Burkholderia cenocepacia faces multiple selective pressures in this highly stressful and fluctuating environment. As a consequence, the initial infecting strain undergoes genetic changes that result in the diversification of genotypes and phenotypes. Whether this clonal expansion influences the pathogenic potential is unclear. The virulence potential of 39 sequential B. cenocepacia (recA lineage IIIA) isolates, corresponding to 3 different clones retrieved from 3 chronically infected CF patients was compared in this study using the non-mammalian infection hosts Galleria mellonella and Caenorhabditis elegans. The isolates used in this retrospective study were picked randomly from selective agar plates as part of a CF Center routine, from the onset of infection until patients' death after 3.5 and 7.5 y or the more recent isolation date after 12.5 y of chronic infection. The infection models proved useful to assess virulence potential diversification, but for some isolates the relative values diverged in C. elegans and G. mellonella. Results also reinforce the concept of the occurrence of clonal diversification and co-existence of multiple phenotypes within the CF lungs, also with respect to pathogenicity. No clear trend of decrease (or increase) of the virulence potential throughout long-term infection was found but there is an apparent tendency for a clone/patient-dependent decrease of virulence when the G. mellonella model was used. The sole avirulent variant in both infection hosts was found to lack the small third replicon previously associated to virulence. Although possible, the in vivo loss of this nonessential megaplasmid was found to be a rare event (1 among a total of 64 isolates examined).

Entities:  

Keywords:  Burkholderia cenocepacia; Caenorhabditis elegans; Galleria mellonella; cystic fibrosis chronic infection; phenotypic diversification; virulence potential

Mesh:

Year:  2016        PMID: 27652671      PMCID: PMC5626231          DOI: 10.1080/21505594.2016.1237334

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  53 in total

1.  Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.

Authors:  Eric E Smith; Danielle G Buckley; Zaining Wu; Channakhone Saenphimmachak; Lucas R Hoffman; David A D'Argenio; Samuel I Miller; Bonnie W Ramsey; David P Speert; Samuel M Moskowitz; Jane L Burns; Rajinder Kaul; Maynard V Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-10       Impact factor: 11.205

Review 2.  Whole genome sequencing of bacteria in cystic fibrosis as a model for bacterial genome adaptation and evolution.

Authors:  Poonam Sharma; Sushim Kumar Gupta; Jean-Marc Rolain
Journal:  Expert Rev Anti Infect Ther       Date:  2014-02-06       Impact factor: 5.091

Review 3.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

4.  Quantitative proteomics (2-D DIGE) reveals molecular strategies employed by Burkholderia cenocepacia to adapt to the airways of cystic fibrosis patients under antimicrobial therapy.

Authors:  Andreia Madeira; Pedro M Santos; Carla P Coutinho; Ana Pinto-de-Oliveira; Isabel Sá-Correia
Journal:  Proteomics       Date:  2011-02-17       Impact factor: 3.984

5.  Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting.

Authors:  E Mahenthiralingam; M E Campbell; D A Henry; D P Speert
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

6.  Role of flagella in host cell invasion by Burkholderia cepacia.

Authors:  Mladen Tomich; Christine A Herfst; Joseph W Golden; Christian D Mohr
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

7.  Identification of Burkholderia cenocepacia strain H111 virulence factors using nonmammalian infection hosts.

Authors:  Stephan Schwager; Kirsty Agnoli; Manuela Köthe; Friederike Feldmann; Michael Givskov; Aurelien Carlier; Leo Eberl
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

8.  A complete lipopolysaccharide inner core oligosaccharide is required for resistance of Burkholderia cenocepacia to antimicrobial peptides and bacterial survival in vivo.

Authors:  Slade A Loutet; Ronald S Flannagan; Cora Kooi; Pamela A Sokol; Miguel A Valvano
Journal:  J Bacteriol       Date:  2006-03       Impact factor: 3.490

9.  Membrane flow during nematode spermiogenesis.

Authors:  T M Roberts; S Ward
Journal:  J Cell Biol       Date:  1982-01       Impact factor: 10.539

10.  Pseudomonas aeruginosa adaptation to lungs of cystic fibrosis patients leads to lowered resistance to phage and protist enemies.

Authors:  Ville-Petri Friman; Melanie Ghoul; Søren Molin; Helle Krogh Johansen; Angus Buckling
Journal:  PLoS One       Date:  2013-09-19       Impact factor: 3.240

View more
  9 in total

1.  Burkholderia cenocepacia virulence microevolution in the CF lung: Variations on a theme.

Authors:  Jonathan J Dennis
Journal:  Virulence       Date:  2016-10-27       Impact factor: 5.882

2.  Using dendritic cells to evaluate how Burkholderia cenocepacia clonal isolates from a chronically infected cystic fibrosis patient subvert immune functions.

Authors:  M Guadalupe Cabral; Marília Pereira; Zélia Silva; Inês Iria; Carla Coutinho; Andreia Lopes; Isabel Sá-Correia; Paula A Videira
Journal:  Med Microbiol Immunol       Date:  2016-12-16       Impact factor: 3.402

3.  1H-NMR-Based Endometabolome Profiles of Burkholderia cenocepacia Clonal Variants Retrieved from a Cystic Fibrosis Patient during Chronic Infection.

Authors:  Ana S Moreira; Artur B Lourenço; Isabel Sá-Correia
Journal:  Front Microbiol       Date:  2016-12-20       Impact factor: 5.640

4.  Structure of O-Antigen and Hybrid Biosynthetic Locus in Burkholderia cenocepacia Clonal Variants Recovered from a Cystic Fibrosis Patient.

Authors:  A A Hassan; Rita F Maldonado; Sandra C Dos Santos; Flaviana Di Lorenzo; Alba Silipo; Carla P Coutinho; Vaughn S Cooper; Antonio Molinaro; Miguel A Valvano; Isabel Sá-Correia
Journal:  Front Microbiol       Date:  2017-06-08       Impact factor: 5.640

5.  A Novel Restraint Device for Injection of Galleria mellonella Larvae that Minimizes the Risk of Accidental Operator Needle Stick Injury.

Authors:  James P Dalton; Benedict Uy; Simon Swift; Siouxsie Wiles
Journal:  Front Cell Infect Microbiol       Date:  2017-03-28       Impact factor: 5.293

6.  Adaptation and Survival of Burkholderia cepacia and B. contaminans During Long-Term Incubation in Saline Solutions Containing Benzalkonium Chloride.

Authors:  Mariana Tavares; Mariya Kozak; Alexandra Balola; Carla P Coutinho; Cláudia P Godinho; A Amir Hassan; Vaughn S Cooper; Isabel Sá-Correia
Journal:  Front Bioeng Biotechnol       Date:  2020-06-26

7.  Burkholderia cepacia Complex Species Differ in the Frequency of Variation of the Lipopolysaccharide O-Antigen Expression During Cystic Fibrosis Chronic Respiratory Infection.

Authors:  A Amir Hassan; Carla P Coutinho; Isabel Sá-Correia
Journal:  Front Cell Infect Microbiol       Date:  2019-07-31       Impact factor: 5.293

8.  Variation of Burkholderia cenocepacia cell wall morphology and mechanical properties during cystic fibrosis lung infection, assessed by atomic force microscopy.

Authors:  A Amir Hassan; Miguel V Vitorino; Tiago Robalo; Mário S Rodrigues; Isabel Sá-Correia
Journal:  Sci Rep       Date:  2019-11-06       Impact factor: 4.379

9.  Metabolomic profiling of Burkholderia cenocepacia in synthetic cystic fibrosis sputum medium reveals nutrient environment-specific production of virulence factors.

Authors:  Olakunle A Jaiyesimi; Andrew C McAvoy; David N Fogg; Neha Garg
Journal:  Sci Rep       Date:  2021-11-01       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.